Applied BioCode signs licensing agreement with Hologic

The combination of Hologic’s Invader® chemistry with Applied BioCode’s Barcoded Magnetic Beads will provide a powerful testing platform for molecular testing laboratories.

Applied BioCode, Inc. today announced that it has signed a License and Supply Agreement (Agreement) with Hologic, Inc., a leading developer, manufacturer and supplier of premium diagnostics products, medical imaging systems and surgical products. Hologic is headquartered in Bedford, MA. Under the Agreement Hologic may purchase Barcoded Magnetic Beads with digital multiplex capabilities for up to 128-plex testing from Applied BioCode. Hologic plans to use the Barcoded Magnetic Beads in conjunction with Hologic’s proprietary Invader® chemistry to create highly multiplexed nucleic acid based tests for the agriculture market.

“We are very pleased to partner with Hologic in such an important and growing area of the molecular testing market. The combination of Hologic’s Invader® chemistry with Applied BioCode’s Barcoded Magnetic Beads will provide a powerful testing platform for molecular testing laboratories,” said Winston Ho, President of Applied BioCode. “We are confident that this new partnership and license agreement will be a valuable addition to Applied BioCode in commercializing our Barcoded Magnetic Bead technology into the global molecular testing markets.”

“Our partnership agreement with Applied BioCode enables us to address the growing need for increased throughput and cost containment through highly multiplexed testing in the agricultural testing market,” said Rohan Hastie, Vice President and General Manager, Hologic Molecular Diagnostics. “Our combined technologies should offer a powerful solution for our customers.”